Cargando…

Molecular Determinants of Ethionamide Resistance in Clinical Isolates of Mycobacterium tuberculosis

Background: Ethionamide and prothionamide are now included in group C of the WHO recommended drugs for the treatment of tuberculosis resistant to rifampicin and multidrug-resistant tuberculosis. The clinical relevance of ethionamide and prothionamide has increased with the wide spread of resistant t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ushtanit, Anastasia, Kulagina, Elena, Mikhailova, Yulia, Makarova, Marina, Safonova, Svetlana, Zimenkov, Danila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868424/ https://www.ncbi.nlm.nih.gov/pubmed/35203736 http://dx.doi.org/10.3390/antibiotics11020133

Ejemplares similares

Perchlozone Resistance in Clinical Isolates of Mycobacterium tuberculosis
por: Ushtanit, Anastasia, et al.
Publicado: (2023)

Genetic Profile of Linezolid-Resistant M. tuberculosis Clinical Strains from Moscow
por: Ushtanit, Anastasia, et al.
Publicado: (2021)

A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia
por: Nosova, Elena Y., et al.
Publicado: (2016)

Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide
por: Zhang, Hai-Nan, et al.
Publicado: (2017)

Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
por: Vilchèze, Catherine, et al.
Publicado: (2008)

EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide
por: Ang, Michelle L. T., et al.
Publicado: (2017)

Revisiting the susceptibility testing of Mycobacterium tuberculosis to ethionamide in solid culture medium
por: Lakshmi, Rajagopalan, et al.
Publicado: (2015)

Variability of Mycobacterium avium Complex Isolates Drug Susceptibility Testing by Broth Microdilution
por: Zimenkov, Danila
Publicado: (2022)

Genetic Characterization Conferred Co-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Isolates from Southern Xinjiang, China
por: Cao, Bin, et al.
Publicado: (2023)

Omics analysis of Mycobacterium tuberculosis isolates uncovers Rv3094c, an ethionamide metabolism-associated gene
por: Wan, Li, et al.
Publicado: (2023)

Dilemmas with ethionamide susceptibility testing of Mycobacterium tuberculosis: A microbiologist & physician's nightmare
por: Varma-Basil, Mandira, et al.
Publicado: (2015)

Increased Susceptibility of Mycobacterium tuberculosis to Ethionamide by Expressing PPs-Induced Rv0560c
por: Seo, Hoonhee, et al.
Publicado: (2022)

Consistency of standard laboratory strain Mycobacterium tuberculosis H(37)Rv with ethionamide susceptibility testing
por: Lakshmi, R., et al.
Publicado: (2012)

Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis
por: Hicks, Nathan D., et al.
Publicado: (2019)

Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of ethA as a Mechanism of Ethionamide Resistance
por: de Welzen, Lynne, et al.
Publicado: (2017)

Ethionamide-induced gynecomastia
por: Dixit, Ramakant, et al.
Publicado: (2012)

Gynecomastia caused by ethionamide
por: Sharma, Parveen K., et al.
Publicado: (2012)

Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays
por: Zimenkov, Danila V, et al.
Publicado: (2013)

Mutation EthA(W21R) confers co-resistance to prothionamide and ethionamide in both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
por: Mugweru, Julius, et al.
Publicado: (2018)

Ethionamide‐induced acneiform drug eruption in a patient with multiresistant tuberculosis
por: Chen, Jessica, et al.
Publicado: (2022)

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
por: Pillay, Samantha, et al.
Publicado: (2022)

A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters
por: Nikiforov, Petar O., et al.
Publicado: (2016)

Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays
por: Nikiforov, Petar O., et al.
Publicado: (2017)

MarR-Dependent Transcriptional Regulation of mmpSL5 Induces Ethionamide Resistance in Mycobacterium abscessus
por: Rodriguez, Ronald, et al.
Publicado: (2023)

Application of Cerium (IV) as an Oxidimetric Agent for the Determination of Ethionamide in Pharmaceutical Formulations
por: Basavaiah, Kanakapura, et al.
Publicado: (2016)

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
por: Costa-Gouveia, Joana, et al.
Publicado: (2017)

Detection of KatG/inhA Mutation to Guide Isoniazid and Ethionamide Use for Drug-resistant Tuberculosis
por: Namburete, Evangelina
Publicado: (2017)

Metabolism and Pharmacokinetics of the Anti-Tuberculosis Drug Ethionamide in a Flavin-Containing Monooxygenase Null Mouse
por: Palmer, Amy L., et al.
Publicado: (2012)

Correlation of inhA mutations and ethionamide susceptibility: Experience from national reference center for tuberculosis
por: Sarin, Rohit, et al.
Publicado: (2021)

Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
por: Costa-Gouveia, Joana, et al.
Publicado: (2018)

Ectopic Expression of Rv0023 Mediates Isoniazid/Ethionamide Tolerance via Altering NADH/NAD(+) Levels in Mycobacterium smegmatis
por: Gupta, Shailesh Kumar, et al.
Publicado: (2020)

Molecular Characterization of katG and inhA Mutations by Genotype MTBDRplus Line Probe Assay To Guide Isoniazid and Ethionamide Use for Drug-Resistant Tuberculosis
por: Ranjan, K. P., et al.
Publicado: (2023)

Molecular Crystal Forms of Antitubercular Ethionamide with Dicarboxylic Acids: Solid-State Properties and a Combined Structural and Spectroscopic Study
por: Bordignon, Simone, et al.
Publicado: (2020)

Molecular characteristics of Mycobacterium tuberculosis drug-resistant isolates from HIV- and HIV+ tuberculosis patients in Russia
por: Panova, Anna E., et al.
Publicado: (2022)

Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system
por: Litvinov, Vitalii, et al.
Publicado: (2018)

Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea
por: Jeon, Se-Mi, et al.
Publicado: (2023)

The Value of the inhA Mutation Detection in Predicting Ethionamide Resistance Using Melting Curve Technology
por: Song, Yanhua, et al.
Publicado: (2021)

Ethionamide and Prothionamide Based Coumarinyl-Thiazole Derivatives: Synthesis, Antitubercular Activity, Toxicity Investigations and Molecular Docking Studies
por: Imran, Mohd
Publicado: (2022)

Graphene oxide-based electrochemical activation of ethionamide towards enhanced biological activity
por: Mulik, Balaji B., et al.
Publicado: (2019)

Molecular Characterization of Prothionamide-Resistant Mycobacterium tuberculosis Isolates in Southern China
por: Tan, Yaoju, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n5q51sr9o32d20nfslvga97aga